Antihyperglycemic, Vasodilator, and Diuretic Activities of Microencapsulated Bioactive Product from Moringa stenopetala Leaves Extract

Table 1

Effects of the microencapsulated bioactive product of M. stenopetala on the body weight of the mice.

Treatment groups	Fastened body weight of the mice (g)
	1st day	7th day	14th day	21st day
Dose 500 mg/kg	30.03 ± 4.16^aA	31.12 ± 4.37^aAB	32.84 ± 4.90^aAB	33.56 ± 4.92^aAB
Dose 750 mg/kg	32.92 ± 3.02^aA	32.40 ± 3.40^aAB	33.01 ± 3.43^aAB	33.12 ± 3.77^aB
Dose 1000 mg/kg	33.84 ± 3.07^aA	33.56 ± 3.75^aAB	32.48 ± 2.76^aAB	33.08 ± 2.96^aB
Positive control	30.57 ± 2.65^aA	31.04 ± 1.89^aAB	31.66 ± 2.36^aAB	32.06 ± 2.03^aBC
Negative control	29.88 ± 1.71^aA	28.49 ± 1.09^abB	27.34 ± 1.03^bcB	26.58 ± 1.72^cC
Normal control	34.08 ± 3.99^aA	36.10 ± 4.10^aA	37.74 ± 3.53^aA	39.76 ± 3.46^aA

Superscript letters with small letters indicate the presence of significant differences () in a raw (in different days), whereas the capital letters indicate the presence of significant differences in a column (different doses of the microencapsulates and control groups).